olprinone has been researched along with Lung Neoplasms in 1 studies
olprinone: RN refers to HCl; structure given in first source
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of postoperative atrial fibrillation was significantly lower in the olprinone group than in the placebo group (10% vs 60%, P < ." | 9.20 | A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer. ( Inoue, M; Maeda, H; Nojiri, T; Okumura, M; Ose, N; Susaki, Y; Takeuchi, Y; Yamamoto, K, 2015) |
| "The incidence of postoperative atrial fibrillation was significantly lower in the olprinone group than in the placebo group (10% vs 60%, P < ." | 5.20 | A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer. ( Inoue, M; Maeda, H; Nojiri, T; Okumura, M; Ose, N; Susaki, Y; Takeuchi, Y; Yamamoto, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nojiri, T | 1 |
| Yamamoto, K | 1 |
| Maeda, H | 1 |
| Takeuchi, Y | 1 |
| Ose, N | 1 |
| Susaki, Y | 1 |
| Inoue, M | 1 |
| Okumura, M | 1 |
1 trial available for olprinone and Lung Neoplasms
| Article | Year |
|---|---|
A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer.
Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up | 2015 |